Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Journal of Clinical Pharmacy and Therapeutics
|
April 26, 2022
The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury
Meiling Zhang, Jia Zhu, Nannan Wang, et al.
Pharmacogenomics
|
April 26, 2022
Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China
Wenpei Liu, Lihuan Lu, Hongqiu Pan, et al.
Fundamental & Clinical Pharmacology
|
June 29, 2025
Effects of FECH Gene Polymorphisms and Serum Ferrochelatase Levels on Antituberculosis Drug-Induced Liver Injury in China
Jingru Cheng, Nannan Wang, Ruina Chen, et al.
Frontiers in Medicine
|
August 31, 2023
A prospective multicenter clinical research study validating the effectiveness and safety of a chest X-ray-based pulmonary tuberculosis screening software JF CXR-1 built on a convolutional neural network algorithm
Yang Yang, Lu Xia, Ping Liu, et al.
Plos One
|
May 21, 2015
Is tuberculosis treatment really free in China? A study comparing two areas with different management models
Sangsang Qiu, Hongqiu Pan, Simin Zhang, et al.
Pakistan Journal of Pharmaceutical Sciences
|
June 25, 2025
Baseline keratin-18 level and risk of anti-tuberculosis drug-induced liver injury: An individual matched case-control study
Bing Han, Min Zhu, Yiwen He, et al.
BMJ Open
|
April 1, 2019
Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study
Miaomiao Yang, Hongqiu Pan, Lihuan Lu, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 11, 2021
Glycemic Trajectories and Treatment Outcomes of Patients with Newly Diagnosed Tuberculosis: A Prospective Study in Eastern China
Qiao Liu, Nannan You, Hongqiu Pan, et al.
Therapie
|
June 16, 2022
The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study
Wenpei Liu, Nannan Wang, Jia Zhu, et al.
Fundamental & Clinical Pharmacology
|
March 1, 2023
Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method
Xinyu Chen, Zhuolu Hao, Hongqiu Pan, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Journal of Clinical Pharmacy and Therapeutics
|
April 26, 2022
The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury
Meiling Zhang, Jia Zhu, Nannan Wang, et al.
Pharmacogenomics
|
April 26, 2022
Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China
Wenpei Liu, Lihuan Lu, Hongqiu Pan, et al.
Fundamental & Clinical Pharmacology
|
June 29, 2025
Effects of FECH Gene Polymorphisms and Serum Ferrochelatase Levels on Antituberculosis Drug-Induced Liver Injury in China
Jingru Cheng, Nannan Wang, Ruina Chen, et al.
Frontiers in Medicine
|
August 31, 2023
A prospective multicenter clinical research study validating the effectiveness and safety of a chest X-ray-based pulmonary tuberculosis screening software JF CXR-1 built on a convolutional neural network algorithm
Yang Yang, Lu Xia, Ping Liu, et al.
Plos One
|
May 21, 2015
Is tuberculosis treatment really free in China? A study comparing two areas with different management models
Sangsang Qiu, Hongqiu Pan, Simin Zhang, et al.
Pakistan Journal of Pharmaceutical Sciences
|
June 25, 2025
Baseline keratin-18 level and risk of anti-tuberculosis drug-induced liver injury: An individual matched case-control study
Bing Han, Min Zhu, Yiwen He, et al.
BMJ Open
|
April 1, 2019
Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study
Miaomiao Yang, Hongqiu Pan, Lihuan Lu, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 11, 2021
Glycemic Trajectories and Treatment Outcomes of Patients with Newly Diagnosed Tuberculosis: A Prospective Study in Eastern China
Qiao Liu, Nannan You, Hongqiu Pan, et al.
Therapie
|
June 16, 2022
The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study
Wenpei Liu, Nannan Wang, Jia Zhu, et al.
Fundamental & Clinical Pharmacology
|
March 1, 2023
Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method
Xinyu Chen, Zhuolu Hao, Hongqiu Pan, et al.
Page
of 5